Living Hope

Informed, Protected, Empowered: Navigating Clinical Trials

In this episode of Living Hope: Your Journey with Pancreatic Cancer, we continue the conversation with Megan Liles from March 5 with a thoughtful and reassuring look at what patients can expect when considering a clinical trial. From understanding the informed consent process to navigating enrollment timing and trial duration, this discussion emphasizes the importance of taking your time, asking questions, and feeling confident in your decisions.

We explore the strong safety measures and oversight systems in place to protect participants, as well as key patient rights—including the ability to withdraw at any time and the importance of understanding how personal data and samples are used. The episode also highlights real patient experiences, the value of support systems, and the growing need for clear, practical tools—like question checklists—to help guide decision-making.

Above all, this continuing conversation offers encouragement: with the right information, support, and resources, patients and families can approach clinical trials with greater clarity, confidence, and hope.

Beyond the Diagnosis: The Emotional Journey of Pancreatic Cancer

In this episode of Living Hope, we are joined by Ana Karen Gonzalez from PanCAN Patient Services to discuss the emotional impact of pancreatic cancer on patients, survivors, and caregivers. Together we explore challenges such as anxiety, depression, PTSD, survivor’s guilt, and scanxiety, while highlighting the importance of support, connection, and open conversations. This episode offers understanding, reassurance, and hope for those navigating the journey.

Clinical Trials Explained: Breaking Myths, Building Hope

Megan Liles, a clinical research professional with over 28 years of experience, joins Living Hope to discuss how clinical trials work and why they are essential to advancing cancer treatments. She shares insights on improving access to research and helping patients and physicians better understand clinical trials as a care option.

This is just the beginning of an important conversation—join us for Part 2: Clinical Trials Explained: Patient Rights, Protections, and What to Expect, where we’ll take a deeper look at the patient experience and what you need to know before considering participation in a clinical trial.

“As long as you speak my name, I shall live forever” is dedicated to Congresswoman Sheila Jackson Lee.  Throughout her life, she dedicated herself to serving others and giving a voice to those who needed it most. Her legacy of leadership, courage, and compassion will continue to inspire generations to come.

 

 

 

Robotics, Sequencing, and Hope: Advances in Pancreatic & HPB Cancer Surgery

In this episode of Living Hope, we welcome Dr. Lavanya Yohanathan a highly respected Hepatopancreatobiliary surgeon (HPB) who specializes in caring for patients with pancreatic, liver, and biliary cancers. Dr. Yohanathan brings deep expertise in some of the most complex areas of HPB care, including advanced treatment sequencing for challenging cancers, innovative robotic surgical techniques, and emerging approaches such as transplant oncology.

Dr. Yohanathan helps us understand why pancreatic cancer surgery is so complex, how surgeons determine the best treatment path, and what new advances are offering real hope to patients today. We explore the importance of multidisciplinary care, the growing role of robotics, and the thoughtful, compassionate way she guides patients through difficult decisions.

Whether you’re a patient, caregiver, advocate, or simply someone seeking clarity and hope, this conversation offers invaluable insight into the rapidly evolving world of HPB cancer care.

 

Can Pancreatic Cancer Become a Curable Disease?

In this episode of Living Hope, we sit down with Dr. Andrew Rakeman, Vice President of Research at the Lustgarten Foundation, who leads the Foundation’s efforts to advance early detection, prevention, and treatment with the goal of making pancreatic cancer a curable disease.

Dr. Rakeman breaks down key developments in the field, including the emerging link between new-onset diabetes and pancreatic cancer, reasons behind long-term recurrence, the status of cancer vaccines, innovations in immunotherapy, strategies to overcome the tumor’s dense barrier, and new progress in KRAS-targeted therapies.

He closes with an inspiring message of hope, highlighting why this is one of the most promising and transformative moments in pancreatic cancer research—and what it means for survivors, patients, families, and the future ahead.

"As long as you speak my name, I shall live forever," is dedicated to Wes Semple

#PancreaticCancerAwareness #LivingHopePodcast #LustgartenFoundation 

A Phone call brings new hope

We kick off Pancreatic Cancer Awareness Month with Nick Pifani — husband, father, marathon runner, and survivor of Stage III inoperable pancreatic cancer. Nick shares how his symptoms led to a shocking diagnosis, his experience with chemo and radiation, and the emotional moment he learned his tumor had become operable.

He reflects on the strength he found through family, faith, and mindset, the life-changing Whipple surgery performed by Dr. Charlie Yeo, and his journey to no evidence of disease. Now an advocate and Survivor Council Co-Chair with PanCAN, Nick offers hope and guidance to anyone facing this diagnosis.

A powerful story of resilience and second chances.

Hope has to have a Plan

Rob Panacci—pancreatic cancer survivor and advocate, sharing how his journey is evolving into a new chapter: the launch of “the novi foundation for cures,” a foundation and program to expand access, innovation, and collaboration in pancreatic cancer.  

This episode was just the introduction. The full breakdown is coming soon.

 

Is Hope on the Horizon for Pancreatic Cancer Patients?

Kerri Kaplan, President and CEO of the Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research. Under her leadership, Lustgarten has helped drive major breakthroughs — from the first FDA-approved immunotherapy for pancreatic cancer to advances in early detection and personalized treatment that offer new hope to patients and families.

Kerri also shares how the Foundation began, the meaning behind its name, and how collaborations like Stand Up To Cancer are accelerating progress in prevention, treatment, and survivorship.

What is Cancer Ghosting?

“Cancer ghosting” describes what happens when friends, coworkers, or even family members withdraw after someone’s cancer diagnosis — not always disappearing completely, but creating painful distance when connection is needed most.  Only on OC Talk Radio.

#LivingHopePodcast #PanCAN #CancerGhosting #PancreaticCancer #SupportNotSilence

From Trials to Hope: A New Approach to Treating Pancreatic Cancer

Shaun Bagai, CEO of RenovoRx, joined us to discuss an innovative approach delivering chemo directly to pancreatic tumors. By targeting the cancer more precisely, this treatment may reduce side effects and improve quality of life. We explored how this approach could transform treatment for those with locally advanced pancreatic cancer, the progress being made in clinical trials, and the hope it brings to patients and families.

#TargetedHope #PancreaticCancerBreakthrough #InnovationInCancerCare #ChemoRedefined #QualityOfLifeMatters #LivingHopePodcast #RenovoRx #PancreaticCancerAwareness #ClinicalTrialsWork #HopeAgainstCancer